Internal Medicine · Bainbridge, GA
NPI
1437218112
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1504 E Evans St
Bainbridge, GA, 39819
Phone (229) 246-6600
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
1,887 services
Medicare patients, 2024
635
Average age 76
Drug cost, 2024
$993K
21,157 prescriptions
Company payments, 2025
$309
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James S Cochran was code 93010 (electrocardiogram), 501 times for 338 patients. In total James S Cochran billed 1,887 services in 34 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 501 | 338 | $5.20 | $2,608 |
| 99213 Office E&M - Established | Facility | 463 | 243 | $40.76 | $19K |
| 99214 Office E&M - Established | Facility | 348 | 212 | $59.20 | $21K |
| 99232 Hospital E&M - Subsequent | Facility | 182 | 43 | $58.28 | $11K |
| 99231 Hospital E&M - Subsequent | Facility | 74 | 25 | $36.92 | $2,732 |
| 99238 Hospital Discharge Management | Facility | 58 | 50 | $58.57 | $3,397 |
| 99214 Office E&M - Established | Office | 43 | 39 | $87.83 | $3,777 |
| 99308 SNF E&M | Office | 39 | 16 | $53.25 | $2,077 |
| 99222 Hospital E&M - Initial | Facility | 39 | 33 | $97.19 | $3,790 |
| 99212 Office E&M - Established | Facility | 27 | 26 | $11.23 | $303 |
| 99213 Office E&M - Established | Office | 20 | 17 | $49.03 | $981 |
| 99221 Hospital E&M - Initial | Facility | 19 | 19 | $61.84 | $1,175 |
By year: 2022 $146K for 3,152 services; 2023 $145K for 2,921 services; 2024 $76K for 1,887 services.
Medicare prescription drug claims, 2024
In 2024, the drug James S Cochran prescribed most often to Medicare patients was Rosuvastatin Calcium, with 962 prescriptions and refills. In total James S Cochran wrote 21,157 Medicare prescriptions that cost $993K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 962 | 1,860 | 200 | $9,194 |
| Atorvastatin Calcium Generic | 766 | 1,468 | 154 | $5,935 |
| Metoprolol Succinate Generic | 745 | 1,320 | 142 | $7,060 |
| Pantoprazole Sodium Generic | 681 | 1,054 | 129 | $5,009 |
| Amlodipine Besylate Generic | 633 | 1,057 | 109 | $2,286 |
| Metformin Hcl Generic | 579 | 1,035 | 109 | $2,952 |
| Furosemide Generic | 550 | 797 | 107 | $2,095 |
| Levothyroxine Sodium Generic | 539 | 920 | 87 | $4,645 |
| Hydrochlorothiazide Generic | 532 | 958 | 99 | $1,426 |
| Nifedipine Er Nifedipine | 528 | 840 | 91 | $6,021 |
| Potassium Chloride Generic | 513 | 671 | 80 | $6,855 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 486 | 837 | 93 | $4,191 |
| Losartan Potassium Generic | 437 | 810 | 88 | $2,695 |
| Prednisone Generic | 358 | 370 | 215 | $885 |
| Eliquis Apixaban | 353 | 439 | 52 | $226K |
Brand drugs: 2,009 claims; generic drugs: 19,045 claims; opioid claims: 489.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James S Cochran $309 ($309 in general payments such as food, travel and fees) from 11 companies. The largest payer was GlaxoSmithKline, LLC. with $97.07.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 6 | $97.07 |
| Exact Sciences Corporation EXAS | 1 | $31.29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $28.99 |
| Abbvie Inc. ABBV | 2 | $28.24 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $23.68 |
| Lundbeck LLC | 1 | $20.42 |
| Novo Nordisk Inc NVO | 1 | $19.5 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $18.91 |
| Corcept Therapeutics CORT | 1 | $18.49 |
| Astellas Pharma US Inc 4503.T | 1 | $15.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.